The Brief International Cognitive Assessment for Multiple Sclerosis is a good diagnostic tool for cognitive impairment in multiple sclerosis.
Why this matters
Cognitive impairment affects up to 65% of people with multiple sclerosis. Although there are numerous neuropsychological batteries to evaluate cognitive function, most of them are time-consuming or require expertise that restricts their use to specialized multiple sclerosis centers. These important findings demonstrate that the Brief International Cognitive Assessment for Multiple Sclerosis is a good screening tool for cognitive impairment that can be used in everyday clinical practice.